Two new xanthone-anthraquinone heterodimers, acremoxanthone C (5) and acremoxanthone D (2), have been isolated from an extract of an unidentified fungus of the order Hypocreales (MSX 17022) by bioactivity-directed fractionation as part of a search for anticancer leads from filamentous fungi. Two known related compounds, acremonidin A (4) and acremonidin C (3) were also isolated, as was a known benzophenone, moniliphenone (1). The structures of these isolates were determined via extensive use of spectroscopic and spectrometric tools in conjunction with comparisons to the literature. All compounds (1-5) were evaluated against a suite of biological assays, including those for cytotoxicity, inhibition of the 20S proteasome, mitochondrial transmembrane potential and nuclear factor-κB.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267898PMC
http://dx.doi.org/10.1038/ja.2011.95DOI Listing

Publication Analysis

Top Keywords

xanthone-anthraquinone heterodimers
8
unidentified fungus
8
fungus order
8
order hypocreales
8
hypocreales msx
8
msx 17022
8
cytotoxic xanthone-anthraquinone
4
heterodimers unidentified
4
17022 xanthone-anthraquinone
4
heterodimers acremoxanthone
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!